Carrat, Fabrice

Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease

Beaugerie, L., Svrcek, M., Seksik, P., Bouvier, A., Simon, T., Allez, M., Brixi, H., Gornet, J., Altwegg, R., Beau, P., et al. (2013) · Gastroenterology

Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection

Cited by 363

Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

Corpechot, C., Carrat, F., Poujol-Robert, A., Gaouar, F., Wendum, D., Chazouillères, O., & Poupon, R. (2012) · Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 351

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 316

Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis

Corpechot, C., Gaouar, F., El Naggar, A., Kemgang, A., Wendum, D., Poupon, R., Carrat, F., & Chazouillères, O. (2014) · Gastroenterology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 300

Primary biliary cirrhosis: Incidence and predictive factors of cirrhosis development in ursodiol-treated patients

Corpechot, C., Carrat, F., Poupon, R., & Poupon, R. (2002) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 169

Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995–1996 epidemic in France

Carrat, F., Tachet, A., Rouzioux, C., Housset, B., & Valleron, A. (1999) · Clinical Infectious Diseases

Influenza Virus Research StudiesRespiratory viral infections research

Cited by 154

Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis

Tanaka, A., Hirohara, J., Nakano, T., Matsumoto, K., Chazouillères, O., Takikawa, H., Hansen, B. E., Carrat, F., & Corpechot, C. (2021) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 148

Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression

Ruiz, A., Lemoinne, S., Carrat, F., Corpechot, C., Chazouillères, O., & Arrivé, L. (2014) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 144

Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis

Dahlqvist, G., Gaouar, F., Carrat, F., Meurisse, S., Chazouillères, O., Poupon, R., Johanet, C., & Corpechot, C. (2017) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 137

Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

Corpechot, C., Carrat, F., Gaouar, F., Chau, F., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Schramm, C., Pares, A., et al. (2022) · Journal of Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 128

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

Corpechot, C., Lemoinne, S., Soret, P.-A., Hansen, B., Hirschfield, G., Gulamhusein, A., Montano-Loza, A. J., Lytvyak, E., Pares, A., Olivas, I., et al. (2024) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 94

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

Charmet, T., Schaeffer, L., Grant, R., Galmiche, S., Chény, O., Von Platen, C., Maurizot, A., Rogoff, A., Omar, F., David, C., et al. (2021) · The Lancet Regional Health - Europe

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 80

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

Soret, P., Lam, L., Carrat, F., Smets, L., Berg, T., Carbone, M., Invernizzi, P., Leroy, V., Trivedi, P., Cazzagon, N., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 78

Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort

Carrat, F., Figoni, J., Henny, J., Desenclos, J.-C., Kab, S., de Lamballerie, X., & Zins, M. (2021) · European Journal of Epidemiology

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 75

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease

Carrat, F., Seksik, P., Colombel, J.-F., Peyrin-Biroulet, L., Beaugerie, L., & the CESAME Study Group (2017) · Alimentary Pharmacology & Therapeutics

Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection

Cited by 49